A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and that many more would like to, but cost is a barrier.
Ornate packaging paired with enticing advertisements that claim expensive shampoos are elixirs to all hair woes can leave one wondering: Should I abandon my $8 drugstore mainstay for a $42 premium brand?